Median Technologies Appoints Ben McDonald to its Board of Directors
10 Oktober 2023 - 5:45PM
Business Wire
Median Technologies (Paris:ALMDT) announced today that Ben
McDonald has joined its Board of Directors, chaired by Oran
Muduroglu. This appointment was approved during the ordinary
shareholders’ meeting, held on October 10th.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231010201331/en/
Ben McDonald (Photo: Business Wire)
Ben McDonald is a Co-Founder, Partner, and Chief Investment
Officer at Aegis Group Partners, a frontier technologies investment
firm. He oversees Aegis Group Partners' investments in a range of
industries, including artificial intelligence, software, biotech,
quantum computing, biomaterials, and clean tech.
Ben serves on the board of directors for Aegis Group Partners
Holdco, Noble Biomaterials, SuperTurbo Technologies, and Next
Generation Turbo. He also served on the board of directors of
Introhive before its sale to Providence Strategic Growth. Prior to
joining Aegis Group Partners, Ben was an investor at Citadel Global
Equities and Ailanthus Capital Management, where he focused on the
technology sector. He holds an MBA from the University of Cambridge
and an HBA from Western University.
«I’m thrilled to welcome Ben McDonald to the board of directors
of Median Technologies. As a Co-Founder, Partner and Chief
Investment Officer at Aegis Group Partners managing the Celestial
Successor Fund, Ben is a long-lasting shareholder of our Company
and has played an instrumental role during our last round of
fundraising in July 2023. Ben’s profound knowledge of the US Health
Tech sector as well as his strong commitment in supporting Health
Tech companies and startups are a real asset for Median and will
very nicely complement our BOD’s expertise,” said Fredrik Brag, CEO
and founder of Median.
“I am delighted to join the board of directors at Median
Technologies. The company has a remarkable track record in
pioneering cutting-edge technologies, particularly in the field of
non-invasive AI-based imaging biomarkers. These biomarkers play an
essential role in the emerging era of personalized and predictive
medicine, allowing physicians to create bespoke treatment plans for
patients, resulting in improved healthcare outcomes and a reduction
in unnecessary invasive procedures,” said Ben McDonald. “I firmly
believe that Median's unwavering dedication to innovation and
excellence will create significant value for patients, hospitals,
insurers, and investors alike.”
About Median Technologies: Median Technologies provides
innovative imaging solutions and services to advance healthcare for
everyone. We harness the power of medical images by using the most
advanced Artificial Intelligence technologies, to increase the
accuracy of diagnosis and treatment of many cancers and other
metabolic diseases at their earliest stages and provide insights
into novel therapies for patients. Our iCRO solutions for medical
image analysis and management in oncology trials and iBiopsy®, our
AI/ML tech-based suite of software as medical devices (SaMD), help
biopharmaceutical companies and clinicians to bring new treatments
and diagnose patients earlier and more accurately. This is how we
are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a
subsidiary in the US and another one in Shanghai, Median has
received the label “Innovative company” by the BPI and is listed on
Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median
is eligible for the French SME equity savings plan scheme
(PEA-PME). For more information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231010201331/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49
24 ggasparetto@actifin.fr
Median Technologies (EU:ALMDT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Median Technologies (EU:ALMDT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024